Correlation Between Kura Oncology and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Kura Oncology and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Kalvista Pharmaceuticals.
Diversification Opportunities for Kura Oncology and Kalvista Pharmaceuticals
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Kura and Kalvista is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Kura Oncology i.e., Kura Oncology and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kura Oncology and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Kalvista Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Kura Oncology is 1.66 times less risky than Kalvista Pharmaceuticals. The stock trades about -0.48 of its potential returns per unit of risk. The Kalvista Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 809.00 in Kalvista Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of 21.00 from holding Kalvista Pharmaceuticals or generate 2.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kura Oncology vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Kura Oncology |
| Kalvista Pharmaceuticals |
Kura Oncology and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kura Oncology and Kalvista Pharmaceuticals
The main advantage of trading using opposite Kura Oncology and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |